| CCL | carcinoma cell line; certified cell line; Charcot-Leyden crystal; continuing care level; critical ca... |
|---|---|
| CDC | calculated date of confinement; cancer diagnosis center; capillary diffusion capacity; cell division... |
| CI | cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar... |
| CMI | carbohydrate metabolism index; care management integration; case mix index; cell-mediated immunity; ... |
| CML | carboxymethyl lysine; cell-mediated lymphocytotoxicity; cell-mediated lympholysis; central motor lat... |
| vascular cell adhesion molecule-1 | Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation. (12 Dec 1998) |
|---|---|
| gargoyle cell | <pathology> Fibroblasts with large deposits of mucopolysaccharide, commonly found in storage diseases such as Hurler syndrome. (18 Nov 1997) |
| pancreatic acinar cell | <pathology> Cells of the pancreas that secrete digestive enzymes, the archetypal secretory cell upon which much of the early work on the sequence of events in the secretory process was done. (18 Nov 1997) |
| vasoformative cell | A cell in the embryo which develops into blood vessel tissue. An embryonic mesenchymal tissue which differentiates into the blood cells and blood vessels. (09 Oct 1997) |
| pancreatic isleT-cell tumours | <radiology> Insulinoma (beta-cell), usually solitary, 85% benign, gastrinoma, small, slow-growing, multiple, 60% malignant, Zollinger-Ellison syndrome: mult. Intractable ulcers, VIPoma, vasoactive intestinal peptide (VIP), WDHA syndrome: watery diarrhoea, hypokalaemia, achlorhydria, Verner-Morrison syndrome, glucagonoma, hyperglycaemia, migratory necrolytic erythema APUDomas, associated with MEN-1 (12 Dec 1998) |
| Paneth cell | <pathology> Coarsely granular secretory cells found in the basal regions of crypts in the small intestine. (18 Nov 1997) |
| malignant giant cell tumour | A type of bone tumour. (12 Dec 1998) |
| veil cell | An antigen-presenting cell that has veil-like cytoplasmic processes and circulates in the blood and lymph. Synonym: veiled cells. (05 Mar 2000) |
| veiled cell | A cell type found in afferent lymph and defined (rather unsatisfactorily) on the basis of its morphology. Probably an accessory cell migrating from the periphery (where it is referred to as a Langerhans cell if in the skin) to the draining lymph node. In the lymph node known as an interdigitating cell and found in the T dependent areas of spleen or lymph nodes, involved in antigen presentation (Class II MHC positive). Has high levels of surface Ia antigens. (18 Nov 1997) |
| malpighian cell | A cell of the stratum spinosum of the epidermis. (05 Mar 2000) |
| G cell | <gastroenterology, pathology> Endocrine cells found in the pyloric gland mucosa (antral mucosa) of the stomach and responsible for the secretion of gastrin. (12 Dec 1998) |
| gemistocytic cell | <cell biology> A round to oval astrocyte cell with abundant cytoplasm containing glial filaments and an eccentric nucleus; may contain two nuclei in the cell hypertrophy of astrocytes. Synonym: gemistocyte, gemistocytic cell, reactive astrocyte, reactive cell. (05 Mar 2000) |
| gene rearrangement, alpha-chain T-cell antigen receptor | Ordered rearrangement of T-cell variable gene regions coding for the alpha-chain of antigen receptors. (12 Dec 1998) |
| gene rearrangement, beta-chain T-cell antigen receptor | Ordered rearrangement of T-cell variable gene regions coding for the beta-chain of antigen receptors. (12 Dec 1998) |
| gene rearrangement, delta-chain T-cell antigen receptor | Ordered rearrangement of T-cell variable gene regions coding for the delta-chain of antigen receptors. (12 Dec 1998) |